Inflation remains way above the Fed’s 2% target despite cooling down. Moreover, although the central bank has indicated a rate hike pause, a cut is not in sight. Amid this, the stable demand for healthcare products should help fundamentally sound medical stock Abbott Laboratories (ABT) perform steadily.
Before discussing and examining the trends of some of its key metrics, let’s look at the market conditions that make the investment case pretty strong for ABT.
